POINT Biopharma Global Current Assets

As of the most recent data (September 2023), PNT shows a current assets of $350M. That compares with $300M in the prior-year period — up 19.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PNT's current assets is now $350M (was $300M) — a 19.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether POINT Biopharma Global is outperforming or lagging.

Tracking PNT's current assets over time shows whether POINT Biopharma Global is scaling, shrinking, or reshaping that part of the business. The current reading is $350M That compares with $300M in the prior-year period — up 19.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has POINT Biopharma Global's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $350M) with ownership activity and broader fundamentals.

POINT Biopharma Global's current assets is $350M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.